HTA / Market Access Strategy Toolkit MAP Value Story & RWE Insight Objection Negotiations & HTA/Payer Pricing Evidence Based Generation/ Handler Strategy HTA/Payer Decision Maker Messages Patient Needs Questions Understanding Support DSP Data Disease State Objection Cost-effectiven Payer Appraisals Resource Handler ess Model Response Hub UK Country Treatment FAQ Reports Protocol GER Core Value IT FDA Message Budget Impact Pediatrics Adjusted NICE Global Payer Comparison Patient Dossier HAS Preference Study TLV HTA Toolkit Patient GBA Testimonials Indirect Local ICER Comparison Clinical Study customizations All content is for Lilly HTA/PAYER engagement/submissions HTA/≠PAYER negotiations internal use only & is regularly updated until market authorizations LOCAL CUSTOMIZATIONS | HTA/PAYER ENGAGEMENT